Table 2.
Clinical features in COVID-19 positives and results of Toxoplasma IgM test
| Variable | All patients N (%) | Toxoplasma IgM (Positive) N (%) | Toxoplasma IgM (Borderline) N (%) | Toxoplasma IgM (Negative) N (%) | P value | |
|---|---|---|---|---|---|---|
| Sociodemographic features | Female | 81 (50.3) | 5 (62.5) | 5 (83.3) | 71 (48.3) | 0.189 |
| Male | 80 (49.7) | 3 (37.5) | 1 (16.7) | 76 (51.7) | ||
| Age [median (IQR)] | 50.0 (23) | 44.5 (26) | 49.5 (24) | 51.0 (23) | 0.464 | |
| Contact with animals | 44 (27.3) | 44 (50.0) | 3 (50.0) | 37 (25.2) | 0.138 | |
| No contact with animals | 117 (72.7) | 44 (50.0) | 3 (50.0) | 110 (74.8) | ||
| Clinical symptoms and signs | Fever > 38 °C | 39 (24.2) | 1 (12.5) | 2 (33.3) | 36 (24.5) | 0.645 |
| Cough | 41 (25.5) | 3 (37.5) | 3 (50.0) | 35 (23.8) | 0.256 | |
| Other | 17 (10.6) | 0 (0.0) | 0 (0.0) | 17 (11.6) | 0.405 | |
| Shortness of breath | 60 (37.3) | 4 (50.0) | 1 (16.7) | 55 (37.4) | 0.439 | |
| Non-specific symptoms | Body pain | 21 (13.0) | 0 (0.0) | 3 (50.0) | 18 (12.2) | 0.014 |
| Headache | 18 (11.2) | 1 (12.5) | 0 (0.0) | 17 (11.6) | 0.673 | |
| Trembling | 13 (8.1) | 0 (0.0) | 0 (0.0) | 13 (8.8) | 0.510 | |
| Diarrhea | 5 (3.1) | 0 (0.0) | 0 (0.0) | 5 (3.4) | 0.782 | |
| Comorbidities | Hypertension | 20 (12.4) | 0 (0.0) | 1 (16.7) | 19 (12.9) | 0.530 |
| Chronic heart disease | 25 (15.5) | 0 (0.0) | 1 (16.7) | 24 (16.3) | 0.641 | |
| Chronic pulmonary disease | 13 (8.1) | 1 (12.5) | 1 (16.7) | 11 (7.5) | 0.645 | |
| No spleen and chronic hepatic disease | 6 (3.7) | 0 (0.0) | 0 (0.0) | 6 (4.1) | 0.743 | |
| Diabetes | 12 (7.5) | 2 (25.0) | 1 (16.7) | 9 (6.1) | 0.096 | |
| Patient condition | Death | 113 (70.6) | 3 (37.5) | 3 (50.0) | 107 (73.3) | 0.051 |
| Recovery (alive) | 47 (29.4) | 5 (62.5) | 3 (50.0) | 39 (26.7) |